INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2011
|
Total net assets |
£97.7m |
|
NAV per share |
174.4p |
|
Share price |
150.5p |
|
Total value of unquoted investments |
£22.8m |
|
Total number of portfolio companies |
62 |
|
Cash |
(1)% NAV |
|
Cash committed and reserved to unquoted investments |
9% NAV |
|
Portfolio companies with < 1 year of cash |
11% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
5.53 |
|
Teva |
5.46 |
|
Cadent |
5.39 |
|
Gilead Sciences |
5.24 |
|
Insulet |
4.42 |
|
Shire |
4.30 |
|
Celgene |
3.73 |
|
Micromet |
3.70 |
|
Actelion |
3.53 |
|
Pharmasset |
3.09 |
|
|
----------- |
|
Total |
44.39 |
|
Geographical Allocation |
% |
|
United States |
72 |
|
Europe |
22 |
|
Israel |
5 |
|
Australia |
2 |
|
Cash |
(1) |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
78 |
|
Unquoted |
23 |
|
Cash |
(1) |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 AUGUST 2011